Joincare Pharmaceutical Group Industry Co.,Ltd.

Joincare Pharmaceutical Group Industry Co.,Ltd.

600380.SS
Joincare Pharmaceutical Group Industry Co.,Ltd.CN flagShanghai Stock Exchange
10.03
CNY
+0.15
- -
18.35BMarket Cap

Joincare Pharmaceutical Group Industry Co.,Ltd. (600380.SS) Stock Split History

Learn about Joincare Pharmaceutical Group Industry Co.,Ltd.'s most recent 221-for-200 basis stock split on October 16, 2018. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Joincare Pharmaceutical Group Industry Co.,Ltd.'s most recent stock split

Split Date: 2018-10-16
Split Ratio: 221:200
Price Before Split: $8.31
Price After Split: $7.52

Developer API

Get 600380.SS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/600380.SS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.10 times more shares (a 221:200 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Joincare Pharmaceutical Group Industry Co.,Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2018-10-16221:200No$8.31$7.52
2012-05-166:5No$6.34$5.28
2010-04-146:5No$13.43$11.19
2008-04-249:5No$17.47$9.71
2006-11-2369:50No$6.88$4.98
2003-11-173:2No$14.76$9.84
2002-06-033:2No$22.23$14.82

About Joincare Pharmaceutical Group Industry Co.,Ltd.

Company overview and industry information

Joincare Pharmaceutical Group Industry Co.,Ltd. (600380.SS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 221-for-200 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Joincare Pharmaceutical Group Industry Co.,Ltd. Summary

Last updated: 7/12/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.